Innovating Works

PROCHIMIA

I-GENE: In vivo Gene Editing by NanotransducErs PROCHIMIA SURFACES SP. Z O.O. participó en un H2020: H2020-FETOPEN-2018-2020 CRISPR/Cas9 and enzyme-based editors hold promise for genome surgery by erasing harmful mutations and re-writing in helpful ones, but face c...
2019-08-30 - 2024-04-30 | Financiado
EVO-NANO: Evolvable platform for programmable nanoparticle based cancer therapies PROCHIMIA SURFACES SP. Z O.O. participó en un H2020: H2020-FETOPEN-2016-2017 EVO-NANO aims to create an integrated cross-disciplinary platform for the artificial evolution and assessment of nanoparticle-based drug del...
2018-05-03 - 2022-03-31 | Financiado
NANOFACTURING: The Development of Medium and Large Scale Sustainable Manufacturing Process Platforms for Clinicall... PROCHIMIA SURFACES SP. Z O.O. participó en un H2020: H2020-NMP-2014-2015 A number of nanomedicine formulations have enabled, or been shown to hold considerable potential for enabling more effective and less toxic...
2014-12-15 - 2019-01-31 | Financiado
GLYFINERY: Sustainable and integrated production of liquid biofuels bioenergy and green chemicals from glycero... PROCHIMIA SURFACES SP. Z O.O. participó en un FP7: The EU target to increase the use of renewable energy carriers in the transportation sector in the coming years has already started to boost...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.